DAFTAR PUSTAKA

1. Santoso SB, Mohardjo, Setiamika M, et al. Pengaruh kemoterapi neoadjuvant

terhadap LMP1 dan rasio CD4+/CD8+ pada karsinoma nasofaring tak
berdiferensiasi. ORLI, 2012; 42(2): 127-132.
2. Agus IG, Eka S, Kuhuwael FG. Alel Gen HLA-A24 pada Sampel Darah TEpi
Penderita Karsinoma Nasofaring di Makassar. Bagian Ilmu Kesehatan Telinga
Hidung Tenggorok Bedah Kepala Leher Fakultas Kedokteran Universitas
Hasanuddin, 2014.
3.

Munir D. Peran HLA pada Karsinoma Nasofaring. Departemen Ilmu

Kesehatan Telinga Hidung Tenggorok, Bedah Kepala Leher Fakultas
Kedokteran Universitas Sumatra Utara. Majalah Kedokteran Nusantara, 2006;
39 (3): 324-330.

4. Cottrill CP, Nutting CM. Tumours of The Nasopharynx. Di dalam Evans PHR,
Montgomery PQ, Gullane PJ (ed). Principles and practice of Head and Neck
Oncology.UK : Martin-Dunitz, 2003. Page 473-81.
5. Wei WI. Nasopharyngeal Cancer. Didalam : Bailey BJ, Johnson JT. Head and
Neck Surgery Otolaryngology, 4thed, vol.2, USA: Lippincott Williams dan
Wilkins. 2006. hlm.657-71.
6. Zou X et al., The Progress on genetic analysis of nasopharyngeal carcinoma.
China: Hindawi Publishing Corporation. 2007.
7. Plant RL. Neoplasms of the Nasopharynx. Di dalam: Snow JB, Wackym PA,
Ballengers Otorhinolaryngology Head and Neck Surgery 17. 2009.
8.

Brennan B. Nasopharyngeal carcinoma. Orph J Rare Dis, 2006; (1):23.

9. Notopuro H, Kentjono WA, Harijono RH. Karsinoma analisis Dasar

Molekular Karsinoma Nasopharyng di Surabaya(jawa timur) .Dalam:
Laporan akhir penelitian tahun I dan II Hibah bersaing perguruan
tinggi.Universitas Airlangga , Surabaya, 2005. pp.1-7.
10. Jeyakumar et. al. Review of nasopharyngeal carcinoma. Ear, Nose and Throat
Journal,2006; 85 (3): 168-184.
11. Cho W. Nasopharyngeal carcinoma : molecular biomarker discovery and
progress. Molecular Cancer, 2007; 6(1) : 1-9.

12. Ganguly NK, Satyanarayana K, Srivastava VK et al. Epidemiological and

etiological factors associated with nasopharyngeal carcinoma. ICMR Bulletin,
2003. (33): 9.
13. Wei WI & Kwong DLW. Current management strategy of nasopharyngeal
carcinoma. clinical and experimental otorhinolaryngology, 2010; 3 (1):1-12.
14. Ahmed & Mohammed. Matrix metalloproteinases 2 and 9 in situ mRNA
expression in colorecral tumors from Iraqi patients. Indian Journal Pathology
& Microbiology ,2011; 54 (1) : 7-14.
15. Chiesa F & De Paoli F. Distant metastasis from nasopharyngeal cancer. ORL,
2001; (63): 214-6.
16. Liu et. al. Increased expression of MMP is correlated with poor prognosis of
nasopharyngeal carcinoma. BMC Cancer Journal, 2010; 10 : 1-7.
17. Guigay J, Temam S, Bourhi J. Nasopharyngeal carcinoma and therapeutic
management: the place of chemotherapy. Annals of Oncology, 2006; 17: 3047.
18. Titcomb CP. High incidence of Nasopharyngeal carcinoma in Asia. J Insur
Med, 2001; 33 :235238.
19. Bast RC, Bookman MA, Knapp RC, Gynecology Tumor Immunology. Dalam
Knapp RC, Bast RC, Bookman MA, eds. Gynecology Oncology. Singapore :
Mc Graw Hill, Inc, 1993; 56-82.
20. Haynes FB, Fauci AS. Disorders of the Immune System. Dalam : Fauci AS,
raunwald E, Isselbacher KJ, eds. Harrisons Principles of Internal Medicine,
Ed XIV, New York : Mc Graw Hill, 1998; 1753-76.
21. Bast CR. Principles of Cancer Biology : Tumor Immunology. Dalam : Devita
VT, Rosenberg SA, Hellman W. eds. Cancer Principles and Practice of
Oncology, Ed V, Philadelphia : Lippincett-Reven, 1997; 267-83.
22. Mitchell MS. Principles of Immunology and Immunotherapy. Dalam :Morrow
CP, Curtin JP, Townsend DE, eds. Synopsis of Gynecologic Oncology. New
York : Churchil Livingstone, 1993; 497-507.

23. Disaia PJ, Creasman WT, Tumor Immunology, Host Defense Mechanism and
Biologic Therapy. Dalam : Disaia JP. Creasman WT. Eds. Clinical Gynecology
Oncology, Ed IV, Philadelphia L: Mosby 1997; 534-75.
24. Anghel I, Dumitru M, Soreanu CC. Nasopharyngeal Carcinoma Analysis of

Risk Factor and Immunological Markers. Chirurgia, 2012; 107: 640-645.